NVIDIA (NVDA) Invests $150 million in Baseten

Group 1 - NVIDIA Corporation (NASDAQ:NVDA) is making significant investments in AI and quantum computing, including a $150 million investment in Baseten, a startup focused on AI inference, which has a valuation of $5 billion after raising $300 million [1][2] - The company previously paid $20 billion to license AI-inference technology from Groq, indicating its strong demand for advanced chips to enhance model response times [2] - NVIDIA and Eli Lilly have established an AI co-innovation lab, committing up to $1 billion over five years to address challenges in the pharmaceutical industry through AI applications [3] Group 2 - The investment in Baseten reflects NVIDIA's strategy to pivot from training models to scaling AI inference capabilities [1] - The collaboration with Eli Lilly aims to leverage AI to solve persistent issues in the pharmaceutical sector, showcasing NVIDIA's commitment to innovation in healthcare [3]